Orteronel and its Impurities
Orteronel (TAK-700) is a nonsteroidal CYP17A1 inhibitor that was being developed for the treatment of cancer. Reference standards of Orteronel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.